Animal models in use by the NCI PREVENT Cancer Preclinical Drug Development Program.

被引：0
|
作者：
Mohammed, Altaf [1 ]
Miller, Mark Steven [1 ]
Glaze, Elizabeth [1 ]
Fernando, Romaine I. [1 ]
Fox, Jennifer [1 ]
Lubet, Ronald A. [1 ]
Sei, Shizuko [1 ]
Shoemaker, Robert H. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 10期
关键词：
D O I：
10.1158/1538-7445.MOUSEMODELS17-B48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B48
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [1] Molecular targets of interest to the NCI PREVENT cancer preclinical drug development program
    Shoemaker, R. H.
    Dunn, B. K.
    Suen, C.
    Lubet, R. A.
    Boring, D. L.
    Klein, B. D.
    Miller, M. S.
    Steele, V. E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 76 - 76
  • [2] Spontaneous and genetically engineered animal models: use in preclinical cancer drug development
    Hansen, K
    Khanna, C
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (06) : 858 - 880
  • [3] The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets
    Shoernaker, Robert H.
    Suen, Chen S.
    Holmes, Cathy A.
    Fay, Judith R.
    Steele, Vernon E.
    [J]. SEMINARS IN ONCOLOGY, 2016, 43 (01) : 189 - 197
  • [4] The role of preclinical animal models in breast cancer drug development
    Clarke R.
    [J]. Breast Cancer Research, 11 (Suppl 3)
  • [5] NEW DRUGS IN THE NCI PRECLINICAL DRUG SCREENING AND DEVELOPMENT PROGRAM
    VENDITTI, J
    PLOWMAN, J
    [J]. INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 106 - 106
  • [6] PRECLINICAL EFFICACY EVALUATION OF POTENTIAL CHEMOPREVENTIVE AGENTS IN ANIMAL CARCINOGENESIS MODELS - METHODS AND RESULTS FROM THE NCI CHEMOPREVENTION DRUG DEVELOPMENT PROGRAM
    STEELE, VE
    MOON, RC
    LUBET, RA
    GRUBBS, CJ
    REDDY, BS
    WARGOVICH, M
    MCCORMICK, DL
    PEREIRA, MA
    CROWELL, JA
    BAGHERI, D
    SIGMAN, CC
    BOONE, CW
    KELLOFF, GJ
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 32 - 54
  • [7] The Use of Animal Models for Cancer Chemoprevention Drug Development
    Steele, Vernon E.
    Lubet, Ronald A.
    [J]. SEMINARS IN ONCOLOGY, 2010, 37 (04) : 327 - 338
  • [8] NCI/FDA program to streamline cancer drug development
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (08) : 52N - 52N
  • [9] THE USE OF ANIMAL-MODELS IN CANCER DRUG DISCOVERY AND DEVELOPMENT
    CURT, GA
    [J]. STEM CELLS, 1994, 12 (01) : 23 - 29
  • [10] NCI to restructure drug development program
    不详
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (06) : 612 - 613
12345